• Donate Now

Enzyme Affected in CGD

Basic understanding of how components of the enzyme NADPH oxidase work together to help kill microbes is fundamental to developing new drug treatments for CGD. The Trust funds projects led by world-renowned scientists.

Previously funded projects

Publications

IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.

© 2001-2007 The Chronic Granulomatous Disorder (CGD) Research Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Site Map | Terms and Conditions | Privacy

Home | What is CGD | About us | Care | Community | Research | Get Involved | Contact | Younger people | For Medics | Media | Links | A-Z | Forum |

You are here : Research / Projects we support / Enzyme defect /

		Projects we support •Research Awards 2007 •Gene Therapy -Current projects -Achievements in Gene Therapy -Previously funded projects •Inflammation -Current projects -Previously funded projects •Aspergillus -Current projects -Previously funded projects •Enzyme defect -Previously funded projects CGD Registry Publications For Researchers Grants available •Clinical Research Training Fellowship How do we decide on funding How to apply for funding Policy Issues